{"id":"keto-acid","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Taste disturbance"}]},"_chembl":null,"_dailymed":{"setId":"a9662e0a-0a8b-4b0c-abe4-f3f4b6fbe7f8","title":"METABOLISM MANAGER (ASCLEPIAS VINCETOXICUM, ECHINACEA (ANGUSTIFOLIA), HYPOTHALAMUS SUIS, CEREBRUM SUIS, HEPAR SUIS, KIDNEY (SUIS), METHYLCOBALAMIN, PANCREAS SUIS, STOMACH (SUIS), AACG-A, AACG-B, CALCAREA CARBONICA, GAMBOGIA, GELSEMIUM SEMPERVIRENS, GRAPHITES, NUX VOMICA, PHYTOLACCA DECANDRA, 7-OXO-DEHYDROEPIANDROSTERONE-3BETA-ACETATE (7-KETO), ADENOSINUM TRIPHOSPHORICUM DINATRUM, INSULINUM (SUIS), SARCOLACTICUM ACIDUM, PROTEUS (VULGARIS)) LIQUID [HEALTHSOURCE OF NEW ENGLAND LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Keto acids are branched-chain amino acid analogs that serve as nitrogen-free precursors for endogenous amino acid synthesis. By providing these substrates, keto acid therapy reduces the nitrogen load on compromised kidneys or liver while maintaining amino acid availability for protein synthesis, thereby improving nutritional status and reducing uremic toxin accumulation in chronic kidney disease or hepatic encephalopathy.","oneSentence":"Keto acid provides essential amino acids and nitrogen-sparing substrates to support protein synthesis and reduce protein catabolism in patients with renal or hepatic disease.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:17:50.118Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic kidney disease with protein-energy wasting"},{"name":"Hepatic encephalopathy"},{"name":"Uremia management in dialysis patients"}]},"trialDetails":[{"nctId":"NCT06065657","phase":"PHASE2, PHASE3","title":"Effect of Nutritional Ketosis on Alcohol Metabolism","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-02-29","conditions":"Ketoses, Metabolic, Ketogenic Dieting, Alcohol Intoxication","enrollment":20},{"nctId":"NCT05469997","phase":"NA","title":"Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2023-03-01","conditions":"Parkinson Disease","enrollment":52},{"nctId":"NCT06876038","phase":"PHASE2","title":"Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions","status":"NOT_YET_RECRUITING","sponsor":"University of Massachusetts, Boston","startDate":"2026-09","conditions":"Oral Cancer, Oral Cavity Cancer, Oral Leukoplakia","enrollment":65},{"nctId":"NCT07225621","phase":"PHASE2","title":"Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"Alpheus Medical, Inc.","startDate":"2026-01-28","conditions":"Glioblastoma, GBM","enrollment":103},{"nctId":"NCT06991257","phase":"PHASE2","title":"A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-06-19","conditions":"Heart Failure","enrollment":620},{"nctId":"NCT04649229","phase":"PHASE4","title":"Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3","status":"COMPLETED","sponsor":"Yale University","startDate":"2021-05-27","conditions":"Heart Failure","enrollment":46},{"nctId":"NCT06417281","phase":"PHASE3","title":"Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA）","status":"COMPLETED","sponsor":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","startDate":"2024-06-19","conditions":"5-aminolevulinic Acid, Malignant Glioma of Brain","enrollment":86},{"nctId":"NCT07144345","phase":"PHASE3","title":"Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-11-19","conditions":"Actinic Keratosis","enrollment":160},{"nctId":"NCT07436546","phase":"NA","title":"Prospective Evaluation of Efficacy of Tumescent Steroid Infiltration in Mandibular Third Molar Surgery: a Split Mouth Randomized Study","status":"COMPLETED","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2025-03-23","conditions":"Impacted Third Molar, Impacted Third Molar Tooth, Third Molar Extraction","enrollment":25},{"nctId":"NCT06665724","phase":"PHASE1","title":"Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)","status":"COMPLETED","sponsor":"Universität Münster","startDate":"2025-01-27","conditions":"Anaplastic Astrocytoma (AA), Anaplastic Oligodendroglioma (AO), Glioblastoma (GBM)","enrollment":16},{"nctId":"NCT07038278","phase":"EARLY_PHASE1","title":"5-AminoLevulinic Acid Aided Resection Margins in Sarcoma","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-04-01","conditions":"Soft Tissue Sarcoma (STS)","enrollment":20},{"nctId":"NCT07076472","phase":"EARLY_PHASE1","title":"Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-14","conditions":"Progressive Glioblastoma, Recurrent Glioblastoma","enrollment":8},{"nctId":"NCT07144852","phase":"PHASE3","title":"Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-11-29","conditions":"Actinic Keratosis","enrollment":260},{"nctId":"NCT05923060","phase":"PHASE2","title":"Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2024-08-25","conditions":"Actinic Keratoses","enrollment":14},{"nctId":"NCT05041166","phase":"PHASE1","title":"A Study of [13C]Pyruvate as an Imaging Agent for Magnetic Resonance Imaging in Healthy Volunteers","status":"ENROLLING_BY_INVITATION","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-09-01","conditions":"Healthy Volunteers","enrollment":50},{"nctId":"NCT06307548","phase":"PHASE1, PHASE2","title":"Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer","status":"SUSPENDED","sponsor":"Roswell Park Cancer Institute","startDate":"2024-07-30","conditions":"Locally Advanced Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Stage III Colorectal Cancer","enrollment":21},{"nctId":"NCT07201376","phase":"","title":"Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically","status":"RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2025-11-14","conditions":"Non-Melanoma Skin Cancer (NMSC), Benign Skin Growth","enrollment":125},{"nctId":"NCT06777511","phase":"","title":"Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients","status":"NOT_YET_RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2026-03-01","conditions":"Amputation, Osseointegration","enrollment":10},{"nctId":"NCT06623201","phase":"PHASE1","title":"Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas","status":"RECRUITING","sponsor":"Nathalie Zeitouni","startDate":"2024-10-07","conditions":"Basal Cell Carcinoma (BCC)","enrollment":20},{"nctId":"NCT02648009","phase":"PHASE1","title":"Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2016-04","conditions":"Hypertension, Hypertrophy","enrollment":112},{"nctId":"NCT07374042","phase":"PHASE3","title":"Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION)","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2026-01-05","conditions":"Kidney Disease, Chronic","enrollment":100},{"nctId":"NCT07359625","phase":"NA","title":"Effects of Ketone Bodies on Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-12-02","conditions":"Insulin Resistance, Obesity & Overweight, Energy Metabolism","enrollment":10},{"nctId":"NCT06907485","phase":"PHASE2","title":"A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients","status":"NOT_YET_RECRUITING","sponsor":"Costas Hadjipanayis","startDate":"2026-08","conditions":"Pediatric Brain Tumor","enrollment":20},{"nctId":"NCT03620773","phase":"PHASE1, PHASE2","title":"Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2018-10-01","conditions":"Type 2 Diabetes Mellitus, Obesity, Bariatric Surgery Candidate","enrollment":24},{"nctId":"NCT07053852","phase":"PHASE1","title":"Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage","status":"COMPLETED","sponsor":"Sherrif Ibrahim","startDate":"2025-06-27","conditions":"Actinic Keratoses, Photodamage","enrollment":10},{"nctId":"NCT06384222","phase":"PHASE2","title":"Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone","status":"RECRUITING","sponsor":"Ivan de Kouchkovsky, MD","startDate":"2024-12-09","conditions":"High Risk Prostate Carcinoma, Prostate Cancer","enrollment":32},{"nctId":"NCT06335875","phase":"NA","title":"Brain Small Chain Fatty Acid Metabolism in Bipolar Disorder: Ketones","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2024-06-07","conditions":"Bipolar Disorder","enrollment":15},{"nctId":"NCT04738162","phase":"PHASE2","title":"Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors","status":"COMPLETED","sponsor":"Universität Münster","startDate":"2020-09-25","conditions":"Brain Tumor, Pediatric","enrollment":78},{"nctId":"NCT07269704","phase":"PHASE1","title":"Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular Disease","status":"COMPLETED","sponsor":"Stanford University","startDate":"2023-08-15","conditions":"Eye Diseases","enrollment":17},{"nctId":"NCT01426529","phase":"PHASE1","title":"Caveolin-1 and Vascular Dysfunction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2010-10-01","conditions":"Hypertension, Insulin Resistance","enrollment":120},{"nctId":"NCT05020912","phase":"PHASE2","title":"Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2021-12-13","conditions":"Basal Cell Carcinoma","enrollment":28},{"nctId":"NCT05695027","phase":"PHASE2, PHASE3","title":"Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Columbia University","startDate":"2023-03-14","conditions":"Primary Open Angle Glaucoma","enrollment":250},{"nctId":"NCT06027619","phase":"PHASE2","title":"Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2023-10-02","conditions":"Actinic Keratosis","enrollment":30},{"nctId":"NCT05720624","phase":"PHASE1","title":"Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2025-10-20","conditions":"Malignant Central Nervous System Neoplasm","enrollment":""},{"nctId":"NCT06369571","phase":"PHASE1, PHASE2","title":"Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet","status":"ENROLLING_BY_INVITATION","sponsor":"Johns Hopkins University","startDate":"2024-10-04","conditions":"Epilepsy, Dyslipidemia","enrollment":22},{"nctId":"NCT05240885","phase":"","title":"Metabolic and Functional Consequences of Aging in Health and Disease","status":"RECRUITING","sponsor":"Texas A&M University","startDate":"2022-03-04","conditions":"Aging","enrollment":100},{"nctId":"NCT05804370","phase":"PHASE3","title":"Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)","status":"RECRUITING","sponsor":"NX Development Corp","startDate":"2024-05-30","conditions":"Ovarian Cancer","enrollment":170},{"nctId":"NCT05752279","phase":"PHASE3","title":"Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis","status":"RECRUITING","sponsor":"The George Institute","startDate":"2024-03-14","conditions":"Diabetic Ketoacidosis","enrollment":680},{"nctId":"NCT02191488","phase":"PHASE1","title":"ALA-induced PpIX Fluorescence During Brain Tumor Resection","status":"ACTIVE_NOT_RECRUITING","sponsor":"David W. Roberts","startDate":"2014-07","conditions":"Brain Tumors","enrollment":540},{"nctId":"NCT05007483","phase":"NA","title":"Efficacy of Diet on Quality of Life in Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Terry L. Wahls","startDate":"2022-02-10","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":162},{"nctId":"NCT05736406","phase":"PHASE1, PHASE2","title":"A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma","status":"RECRUITING","sponsor":"Hemerion Therapeutics","startDate":"2024-02-20","conditions":"Primary Glioblastoma","enrollment":12},{"nctId":"NCT04815083","phase":"PHASE3","title":"Fluorescence Imaging of Carcinoma During Breast Conserving Surgery","status":"TERMINATED","sponsor":"SBI ALApharma Canada, Inc.","startDate":"2021-04-27","conditions":"Breast Neoplasm Female, Breast Cancer","enrollment":57},{"nctId":"NCT03502967","phase":"EARLY_PHASE1","title":"Imaging of Traumatic Brain Injury Metabolism Using Hyperpolarized Carbon-13 Pyruvate","status":"ENROLLING_BY_INVITATION","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-06-01","conditions":"Traumatic Brain Injury","enrollment":60},{"nctId":"NCT04113109","phase":"PHASE4","title":"Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2019-11-01","conditions":"Heart Failure","enrollment":46},{"nctId":"NCT06796660","phase":"EARLY_PHASE1","title":"Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Liu Zhanghong","startDate":"2025-09-01","conditions":"Renal Insufficiency, Chronic","enrollment":70},{"nctId":"NCT04274179","phase":"PHASE3","title":"Ketogenic Diet for New-Onset Absence Epilepsy","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2020-08-10","conditions":"Absence Epilepsy, Ketogenic Dieting, Epilepsy, Absence","enrollment":40},{"nctId":"NCT07117903","phase":"NA","title":"Zhongshan Ketogenic Diet Study 1","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-08-10","conditions":"Platelet Function and Thrombus Formation","enrollment":80},{"nctId":"NCT02691923","phase":"PHASE2","title":"Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker","status":"RECRUITING","sponsor":"David W. Roberts","startDate":"2016-03","conditions":"Brain Cancer","enrollment":30},{"nctId":"NCT05101798","phase":"PHASE2","title":"The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2021-09-14","conditions":"Neoplasm, Skull Base Neoplasm","enrollment":7},{"nctId":"NCT05507892","phase":"PHASE2","title":"Renal Mechanism of SGLT2 Inhibition","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-10-10","conditions":"Type 2 Diabetes, Diabetic Kidney Disease","enrollment":40},{"nctId":"NCT04965987","phase":"PHASE1","title":"Oxaloacetate in Myasthenia Gravis","status":"WITHDRAWN","sponsor":"University of Kansas Medical Center","startDate":"2025-08","conditions":"Myasthenia Gravis","enrollment":""},{"nctId":"NCT07027670","phase":"PHASE2","title":"Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-02-01","conditions":"Cardiac Surgical Procedures, Coronary Artery Bypass, Aortic Valve Disease","enrollment":48},{"nctId":"NCT07031128","phase":"PHASE4","title":"Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2024-06-11","conditions":"CABG","enrollment":250},{"nctId":"NCT05362409","phase":"PHASE1","title":"Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma","status":"COMPLETED","sponsor":"Alpheus Medical, Inc.","startDate":"2022-06-29","conditions":"High Grade Glioma","enrollment":22},{"nctId":"NCT05065372","phase":"PHASE1","title":"MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes","status":"RECRUITING","sponsor":"Kalie Tommerdahl","startDate":"2022-07-01","conditions":"Type 1 Diabetes, Diabetic Kidney Disease, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT06075914","phase":"NA","title":"Ketone Conferred Resiliency Against Sleep Restriction With Nutritional Intervention.","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2023-05-01","conditions":"Sleep Deprivation, Nutritional Intervention","enrollment":60},{"nctId":"NCT03897491","phase":"PHASE2","title":"PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"photonamic GmbH & Co. KG","startDate":"2021-09-03","conditions":"Glioblastoma","enrollment":20},{"nctId":"NCT06160492","phase":"PHASE3","title":"Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)","status":"RECRUITING","sponsor":"Lee's Pharmaceutical Limited","startDate":"2025-04-14","conditions":"5-aminolevulinic Acid, Fluorescence-guided Resection","enrollment":144},{"nctId":"NCT02728388","phase":"PHASE2","title":"Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II","status":"RECRUITING","sponsor":"Donald Basel","startDate":"2016-08","conditions":"NEUROFIBROMATOSIS 1","enrollment":30},{"nctId":"NCT06948552","phase":"PHASE2","title":"Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA","status":"NOT_YET_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2025-05","conditions":"Upper Tract Urothelial Carcinoma","enrollment":10},{"nctId":"NCT06896552","phase":"PHASE1, PHASE2","title":"Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.","status":"NOT_YET_RECRUITING","sponsor":"Rabin Medical Center","startDate":"2025-04","conditions":"Cancer, Immunotherapy, Ketogenic Diet","enrollment":60},{"nctId":"NCT05008276","phase":"","title":"Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)","status":"RECRUITING","sponsor":"Petter Bjornstad","startDate":"2021-09-27","conditions":"Type 2 Diabetes Mellitus, Diabetic Kidney Disease, Adolescent Obesity","enrollment":100},{"nctId":"NCT05694624","phase":"","title":"Investigations Into Sepsis-associated Acute Kidney Injury","status":"RECRUITING","sponsor":"University Hospital of North Norway","startDate":"2023-08-14","conditions":"Acute Kidney Injury","enrollment":20},{"nctId":"NCT04469699","phase":"PHASE2","title":"Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma","status":"TERMINATED","sponsor":"University Hospital Muenster","startDate":"2021-04-12","conditions":"Glioblastoma Multiforme, Adult","enrollment":30},{"nctId":"NCT01689935","phase":"PHASE1","title":"Reduced Side-Effects of Photodynamic Therapy for the Treatment of Moderate to Severe Acne (i-PDT)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-11-01","conditions":"Acne Vulgaris","enrollment":35},{"nctId":"NCT06159842","phase":"PHASE2","title":"Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)","status":"COMPLETED","sponsor":"The Center for Clinical and Cosmetic Research","startDate":"2023-08-08","conditions":"Facial Cutaneous Squamous Cell Carcinoma in Situ","enrollment":32},{"nctId":"NCT05273372","phase":"NA","title":"RESTORE ME -- RCT of Oxaloacetate on Improving Fatigue in ME/CFS","status":"COMPLETED","sponsor":"Terra Biological LLC","startDate":"2022-03-15","conditions":"Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Fatigue","enrollment":82},{"nctId":"NCT05840237","phase":"NA","title":"REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID","status":"COMPLETED","sponsor":"Terra Biological LLC","startDate":"2023-06-01","conditions":"Post-COVID-19 Syndrome, Fatigue Syndrome, Chronic","enrollment":70},{"nctId":"NCT03066843","phase":"NA","title":"Photodynamic Therapy Incubation Times for Actinic Keratosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2017-03-01","conditions":"Actinic Keratoses","enrollment":60},{"nctId":"NCT06745999","phase":"PHASE4","title":"Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face","status":"RECRUITING","sponsor":"Psoriasis Treatment Center of Central New Jersey","startDate":"2023-05-03","conditions":"Actinic Keratoses","enrollment":40},{"nctId":"NCT05590689","phase":"PHASE1, PHASE2","title":"Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor","status":"RECRUITING","sponsor":"Universität Münster","startDate":"2022-11-09","conditions":"Glioblastoma","enrollment":34},{"nctId":"NCT05709600","phase":"NA","title":"Dietary Interventions During Living Kidney Donations","status":"RECRUITING","sponsor":"University of Cologne","startDate":"2023-02-01","conditions":"Living-Kidney Donors","enrollment":80},{"nctId":"NCT06645691","phase":"PHASE2","title":"Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body","status":"RECRUITING","sponsor":"National Heart Centre Singapore","startDate":"2024-10-17","conditions":"Heart Failure, Cardiometabolic Syndrome, Cancer Diagnosis","enrollment":200},{"nctId":"NCT05119010","phase":"NA","title":"A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma","status":"TERMINATED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2023-03-24","conditions":"Metastatic Renal Cell Carcinoma","enrollment":3},{"nctId":"NCT04845919","phase":"PHASE2","title":"Sonodynamic Therapy with ExAblate System in Glioblastoma Patients","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2023-02-22","conditions":"Glioblastoma Multiforme","enrollment":5},{"nctId":"NCT06646809","phase":"PHASE3","title":"Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2024-05-09","conditions":"Colorectal Cancer","enrollment":80},{"nctId":"NCT06452563","phase":"PHASE4","title":"Amino Acids Supplementation and Exercise Intervention in Hemodialysis Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mansoura University","startDate":"2024-05-12","conditions":"Hemodialysis Complication, Malnutrition","enrollment":100},{"nctId":"NCT06577311","phase":"PHASE2","title":"Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)","status":"RECRUITING","sponsor":"The Center for Clinical and Cosmetic Research","startDate":"2024-08-14","conditions":"Cutaneous Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT05952544","phase":"","title":"Effect of Protein Restriction Plus EAA/KA Supplementation on GFR Decline in CKD","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-07-20","conditions":"Chronic Kidney Diseases","enrollment":400},{"nctId":"NCT06252727","phase":"PHASE1","title":"Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)","status":"WITHDRAWN","sponsor":"University of California, Davis","startDate":"2024-07","conditions":"Soft Tissue Sarcoma, Soft Tissue Sarcoma Adult","enrollment":""},{"nctId":"NCT03963102","phase":"PHASE4","title":"Duration of Ameluz Application in Acral Actinic Keratoses Response","status":"TERMINATED","sponsor":"Royal Cornwall Hospitals Trust","startDate":"2019-10-30","conditions":"Actinic Keratoses, Photodamaged Skin","enrollment":28},{"nctId":"NCT03327831","phase":"PHASE4","title":"Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2015-04","conditions":"Actinic Keratosis","enrollment":30},{"nctId":"NCT05279118","phase":"PHASE2, PHASE3","title":"Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2022-04-18","conditions":"Ketogenic Diet, West Syndrome, Infantile Spasm","enrollment":80},{"nctId":"NCT04305470","phase":"PHASE3","title":"Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma","status":"COMPLETED","sponsor":"NX Development Corp","startDate":"2020-10-28","conditions":"Meningioma","enrollment":108},{"nctId":"NCT04204889","phase":"PHASE1","title":"Trial of Oxaloacetate in ALS","status":"COMPLETED","sponsor":"Omar Jawdat","startDate":"2020-03-17","conditions":"ALS","enrollment":18},{"nctId":"NCT06392516","phase":"NA","title":"Ketoacid Analogues Intradialytic Effect on Inflammation","status":"NOT_YET_RECRUITING","sponsor":"RSUP Fatmawati","startDate":"2024-04-29","conditions":"Hemodialysis Complication","enrollment":86},{"nctId":"NCT06387186","phase":"PHASE1","title":"Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy","status":"NOT_YET_RECRUITING","sponsor":"Elizabeth Anne Thiele","startDate":"2024-04","conditions":"Refractory Epilepsy, Drug Resistant Epilepsy","enrollment":15},{"nctId":"NCT05319990","phase":"","title":"Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-03-09","conditions":"Type 1 Diabetes, Diabetic Kidney Disease, Diabetes Complications","enrollment":100},{"nctId":"NCT06308757","phase":"NA","title":"Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis","status":"RECRUITING","sponsor":"University of Bologna","startDate":"2021-09-29","conditions":"NASH, NAFLD, Obesity","enrollment":42},{"nctId":"NCT06275347","phase":"NA","title":"Very Low Calorie Ketogenic Low-fat Diet (VLCKLFD)","status":"COMPLETED","sponsor":"Universidad Veracruzana","startDate":"2021-01-15","conditions":"Obesity","enrollment":88},{"nctId":"NCT04164849","phase":"PHASE1, PHASE2","title":"Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid","status":"COMPLETED","sponsor":"University Hospital, Akershus","startDate":"2019-11-22","conditions":"Crohn Disease","enrollment":7},{"nctId":"NCT01128218","phase":"PHASE1, PHASE2","title":"A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors","status":"COMPLETED","sponsor":"Southern Illinois University","startDate":"2011-03","conditions":"Brain Neoplasms","enrollment":33},{"nctId":"NCT01502280","phase":"PHASE3","title":"Fluorescence-guided Surgery for Low- and High-grade Gliomas","status":"COMPLETED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2010-11","conditions":"Glioma","enrollment":127},{"nctId":"NCT05159570","phase":"NA","title":"Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Metabolic Effects. (KETO-HFpEF-Metabolic)","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2023-02-01","conditions":"Heart Failure With Preserved Ejection Fraction, Diabetes Mellitus, Type 2, Ketonemia","enrollment":10},{"nctId":"NCT06046755","phase":"NA","title":"Nutritional Intervention-induced Weight Loss During the Oncological Treatment of Obesity-related Breast Cancer","status":"UNKNOWN","sponsor":"Hospital Clinico Universitario de Santiago","startDate":"2023-10-15","conditions":"Breast Cancer, Obesity, Weight Change, Body","enrollment":220},{"nctId":"NCT03584217","phase":"PHASE1, PHASE2","title":"Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study","status":"UNKNOWN","sponsor":"University of Colorado, Denver","startDate":"2018-10-01","conditions":"Type 2 Diabetes Mellitus, Obesity, Nephropathy","enrollment":100},{"nctId":"NCT01966120","phase":"PHASE3","title":"Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2013-10","conditions":"Actinic Keratosis","enrollment":87},{"nctId":"NCT05850377","phase":"","title":"5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas","status":"NOT_YET_RECRUITING","sponsor":"Sociedad de Lucha Contra el Cáncer del Ecuador","startDate":"2023-06-01","conditions":"High Grade Glioma, Glioma, Glioma, Malignant","enrollment":90},{"nctId":"NCT05263401","phase":"NA","title":"Keto Drinks as a Meal Primer in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2022-01-01","conditions":"Type 2 Diabetes, Ketoses, Metabolic","enrollment":14},{"nctId":"NCT04074668","phase":"","title":"Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-01-01","conditions":"Diabetic Kidney Disease, Type 1 Diabetes, Diabetes","enrollment":58}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"CHRONIC KIDNEY DISEASE"},{"count":1,"reaction":"DISEASE PROGRESSION"},{"count":1,"reaction":"DRUG LEVEL INCREASED"},{"count":1,"reaction":"HEPATIC CIRRHOSIS"},{"count":1,"reaction":"HEPATITIS"},{"count":1,"reaction":"LIVER INJURY"},{"count":1,"reaction":"MEDICATION ERROR"},{"count":1,"reaction":"NEPHROPATHY TOXIC"},{"count":1,"reaction":"PLEURAL EFFUSION"},{"count":1,"reaction":"RESPIRATORY TRACT INFECTION"}],"_approvalHistory":[],"publicationCount":1964,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Compound α-Ketoacid Tablets"],"phase":"marketed","status":"active","brandName":"Keto Acid","genericName":"Keto Acid","companyName":"Peking University First Hospital","companyId":"peking-university-first-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Keto acid provides essential amino acids and nitrogen-sparing substrates to support protein synthesis and reduce protein catabolism in patients with renal or hepatic disease. Used for Chronic kidney disease with protein-energy wasting, Hepatic encephalopathy, Uremia management in dialysis patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}